Risultati di ricerca
5 giorni fa · Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical Officer. AUSTIN, Texas, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company developing novel therapeutics f...
- 7.90M
- 57.31M
- 8.12M
- 5.37M
15 mag 2024 · We believe these data demonstrate a new and potentially best-in-class approach to targeting the PD-1-PD-L1 axis.” “MT-6402 appears generally well-tolerated at the 63 and 83 mcg/kg doses with no Grade 4 or Grade 5 adverse events and no instances of CLS seen at any dose,” said Dr. Maurizio Voi, Chief Medical Officer of Molecular ...
6 giorni fa · Molecular Templates, Inc. Announces Cessation of Maurizio Voi as Chief Medical Officer, Effective April 30, 2024 Apr 13 Molecular Templates, Inc. Presents Interim Data from Mt-6402 Phase I Study in Patients with Pd-L1+ Solid Tumors At the 2024 American Association for Cancer Research Annual Meeting
4 giorni fa · Maurizio e Renata di Uomini e donne differenza di età. Nonostante la differenza di età, i due sono decisi a continuare la loro conoscenza, trovandosi bene insieme. “Se la differenza d’età ...
14 mag 2024 · Molecular Templates, Inc. Announces Cessation of Maurizio Voi as Chief Medical Officer, Effective April 30, 2024 CI Apr. 09
4 giorni fa · Molecular Templates appoints Maurizio Voi as chief medical officer September 30, 2023 | finanznachrichten.de Molecular Templates, Inc.: Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical Officer
4 giorni fa · “Ecco a voi la Top Ten delle città in balia delle risorse” Un Maurizio Belpietro da applausi seppellisce definitivamente la feccia rossa al servizio di Davos Maggio 24, 2024 1 minute read
